Archives
-
E. coli Uracil-DNA Glycosylase (UDG) Workflow
2026-09-27
E. coli Uracil-DNA Glycosylase (UDG), SKU K1107, removes uracil from single- and double-stranded DNA and can support PCR product contamination elimination when contaminating DNA contains uracil. It is intended for research DNA workflows, not RNA, oligonucleotides shorter than six bases, or diagnostic and medical applications.
-
Annexin V-Cy5 Apoptosis Kit in Microglia Studies
2026-09-26
Pair rapid Annexin V apoptosis detection with lysosomal readouts to distinguish cell death from impaired microglial digestion. A practical workflow for microscopy and flow cytometry helps interpret the reversible mestranol-associated phenotype without treating lysosomal stress as apoptosis.
-
A 4Q Framework for Stable, Efficient mRNA Delivery
2026-09-25
Shi and colleagues propose a 4Q design framework that treats storage and in vivo stability, tissue diffusion, cell entry, and intracellular release as linked determinants of mRNA delivery. Their catechol-containing, disulfide-bearing polymer formed polyplexes with room-temperature stability exceeding two weeks and produced substantially stronger in vivo reporter signal than a jetPEI comparator in the tested model.
-
PPT: ERα Signaling Workflows in LUAD
2026-09-25
PPT provides a selective way to test whether ERα activation changes candidate gene or cell-state readouts in estrogen-receptor-positive models. This practical guide connects its use to a female lung adenocarcinoma study while distinguishing a useful experimental hypothesis from evidence the study did not establish.
-
EZ Cap™ Cy5 EGFP mRNA: Beyond Uptake
2026-09-24
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) pairs a Cy5-labeled mRNA delivery signal with EGFP expression to distinguish cellular association from productive translation. This article connects that dual-readout strategy to new structural insights into RNA–polymer assemblies and explains how to interpret reporter results without overcalling delivery.
-
(Z)-4-Hydroxytamoxifen in Relapse Research
2026-09-24
Discover how (Z)-4-Hydroxytamoxifen can help dissect estrogen receptor signaling while keeping endocrine pharmacology distinct from genetic tumor-relapse models. A 2025 proliferation-tracing study offers practical lessons for experimental timing, cell-state analysis, and interpreting recurrence.
-
Annexin V-Cy5 Apoptosis Kit in Microglia
2026-09-23
Learn how the Annexin V-Cy5 Apoptosis Kit can help distinguish phosphatidylserine exposure from lysosomal dysfunction in microglia. This article translates a reversible zebrafish microglial stress model into practical choices for apoptosis assay design and interpretation.
-
PINK1/Park2 Mitophagy in NAFLD
2026-09-23
The reference study links Park2-dependent mitophagy with reduced lipid accumulation, inflammatory signaling, and mitochondrial injury in an oleic acid-based cellular model of non-alcoholic fatty liver disease. Its combination of Park2 gain- and loss-of-function experiments with mitochondrial imaging and LC3 localization provides mechanistic evidence, while the lack of in vivo validation leaves important questions about clinical transferability.
-
EZ Cap EGFP mRNA 5-moUTP for Assay Control
2026-09-22
Discover how EZ Cap EGFP mRNA 5-moUTP can function as more than an EGFP reporter: it provides a practical control for mRNA delivery, translation efficiency, stability, and immune-compatible assay design.
-
Estradiol–Autophagy Axis in Perimenopausal Aging
2026-09-22
This study integrates NHANES analyses, network pharmacology, and perimenopausal mouse experiments to examine how declining estradiol relates to cardiometabolic and renal disease risk. Its central contribution is evidence that receptor-dependent autophagy, including mTOR-associated signaling, helps preserve the heart, aorta, and kidneys during estrogen loss.
-
From EGFP Signal to Translational Confidence
2026-09-21
A mechanistic and strategic guide to using EZ Cap™ EGFP mRNA (5-moUTP) as a benchmark for mRNA delivery, translation, innate immune activation, and translational decision-making.
-
Estradiol, ER Signaling, and T-Cell Recovery After Shock
2026-09-21
The reference study shows that estradiol restores splenic CD4+ T-cell proliferation and cytokine production after hemorrhagic shock by engaging ERα and GPR30-associated signaling while suppressing endoplasmic reticulum stress. Its pharmacologic design separates receptor subtype effects from ER-stress effects, offering a useful framework for studying hormone–immune interactions while emphasizing the limits of translation from an acute rat model.
-
Thapsigargin: From Ca2+ Flux to Necroptosis
2026-09-20
Thapsigargin is a potent SERCA pump inhibitor for resolving how ER calcium depletion reshapes cell-death signaling. This article develops an assay framework linking calcium kinetics, ER stress, apoptosis, and necroptosis without treating them as interchangeable outcomes.
-
4μ8C and ER Stress: Branch-Specific Assays
2026-09-19
Explore how 4μ8C can resolve IRE1α RNase signaling from PERK-driven ER stress, with practical guidance for hypoxia response modulation, cancer research, and emerging inflammation models.
-
EZ Cap™ ER-EGFP Probe mRNA Guide
2026-09-18
EZ Cap™ ER-EGFP Probe mRNA (m1Ψ) is an ER-directed fluorescent mRNA probe for visualizing reporter signal in cell-based experiments. The cited osteogenesis study links PFKM suppression to MERC expansion, calcium-dependent DRP1 remodeling, and mitochondrial quality control, but it does not evaluate this product directly.